Literature DB >> 9988162

Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.

A K Rowe1, J Bertolli, A S Khan, R Mukunu, J J Muyembe-Tamfum, D Bressler, A J Williams, C J Peters, L Rodriguez, H Feldmann, S T Nichol, P E Rollin, T G Ksiazek.   

Abstract

A cohort of convalescent Ebola hemorrhagic fever (EHF) patients and their household contacts (HHCs) were studied prospectively to determine if convalescent body fluids contain Ebola virus and if secondary transmission occurs during convalescence. Twenty-nine EHF convalescents and 152 HHCs were monitored for up to 21 months. Blood specimens were obtained and symptom information was collected from convalescents and their HHCs; other body fluid specimens were also obtained from convalescents. Arthralgias and myalgia were reported significantly more often by convalescents than HHCs. Evidence of Ebola virus was detected by reverse transcription-polymerase chain reaction in semen specimens up to 91 days after disease onset; however, these and all other non-blood body fluids tested negative by virus isolation. Among 81 initially antibody negative HHCs, none became antibody positive. Blood specimens of 5 HHCs not identified as EHF patients were initially antibody positive. No direct evidence of convalescent-to-HHC transmission of EHF was found, although the semen of convalescents may be infectious. The existence of initially antibody-positive HHCs suggests that mild cases of Ebola virus infection occurred and that the full extent of the EHF epidemic was probably underestimated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9988162     DOI: 10.1086/514318

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  124 in total

1.  Robust and sustained immune activation in human Ebola virus infection.

Authors:  Judith N Mandl; Mark B Feinberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-07       Impact factor: 11.205

Review 2.  Ebola Virus Disease: Focus on Children.

Authors:  Athena P Kourtis; Kristie Appelgren; Michelle S Chevalier; Anita McElroy
Journal:  Pediatr Infect Dis J       Date:  2015-08       Impact factor: 2.129

3.  Understanding the dynamics of Ebola epidemics.

Authors:  J Legrand; R F Grais; P Y Boelle; A J Valleron; A Flahault
Journal:  Epidemiol Infect       Date:  2006-09-26       Impact factor: 2.451

4.  Assessing the international spreading risk associated with the 2014 west african ebola outbreak.

Authors:  Marcelo F C Gomes; Ana Pastore Y Piontti; Luca Rossi; Dennis Chao; Ira Longini; M Elizabeth Halloran; Alessandro Vespignani
Journal:  PLoS Curr       Date:  2014-09-02

Review 5.  Ebola virus disease.

Authors:  Nicholas J Beeching; Manuel Fenech; Catherine F Houlihan
Journal:  BMJ       Date:  2014-12-10

6.  The cost of an Ebola case.

Authors:  Sarah M Bartsch; Katrin Gorham; Bruce Y Lee
Journal:  Pathog Glob Health       Date:  2015-01-11       Impact factor: 2.894

7.  Laboratory diagnosis of Ebola virus disease.

Authors:  Philippe Martin; Kevin B Laupland; Eric H Frost; Louis Valiquette
Journal:  Intensive Care Med       Date:  2015-01-31       Impact factor: 17.440

Review 8.  Insights from clinical research completed during the west Africa Ebola virus disease epidemic.

Authors:  Amanda Rojek; Peter Horby; Jake Dunning
Journal:  Lancet Infect Dis       Date:  2017-04-28       Impact factor: 25.071

Review 9.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

10.  Immunoglobulin G in Ebola outbreak survivors, Gabon.

Authors:  Nadia Wauquier; Pierre Becquart; Clélia Gasquet; Eric M Leroy
Journal:  Emerg Infect Dis       Date:  2009-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.